EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Retinoblastoma in Tanzania; Survival and prognostic factors: A retrospective cohort study

Heavenlight Masuki, Celina Mhina, A Sanyiwa

Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA) · 25.02.2025 · 13 (02)

DOI: 10.64666/joecsa.2024.66 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA), online erschienen am 25.02.2025. Verfasst von Heavenlight Masuki und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the 3-year survival rate and prognostic factors among patients with retinoblastoma diagnosed at Muhimbili National Hospital from January 2016 to December 2018.

Methods

A retrospective cohort study was conducted. Participants were consecutively recruited. Data were collected using a questionnaire. Variables included demographics, clinical presentation, treatment, and survival time. Statistical analysis was performed using Stata version11. Kaplan-Meier survival analysis was used to assess the survival rates, while the log rank test determined statistical significance. The hazard ratios were calculated using Cox regression. A P value < 0.005 was considered statistically significant.

Results

A total of 166 children were studied, with 69.3% having unilateral retinoblastoma and 30.7% bilateral.Fifty percent of the children were females. The overall mean age at diagnosis was 25.56 ± 15.56 months. The participant’s mean age at diagnosis was 18.7± 11.6 months for bilateral and 31.3± 20.4 months for unilateral retinoblastoma. The most common complaints were leukocoria (90.4%) and eye protrusion (46.4%). The mean duration of symptoms was 7.9±5.3 months, and the mean total delay time was 9.4±5.6 months. At presentation, 51.8% of the study participants had disease stage 3 and 4 according to the International Retinoblastoma Staging System. The 3-year Kaplan-Meier survival rate was 52.3%. Multivariate Cox regression analysis identified age at diagnosis > 24 months (p=0.001), failure to complete treatment (p=24 months, failure to complete treatment, and extraocular disease invasion were associated with a lower survival rate.

Zitieren

APA

Masuki, H., Mhina, C., & Sanyiwa, A. (2025). Retinoblastoma in Tanzania; Survival and prognostic factors: A retrospective cohort study. Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA), 13(02). https://doi.org/10.64666/joecsa.2024.66

Vancouver

Masuki H, Mhina C, Sanyiwa A. Retinoblastoma in Tanzania; Survival and prognostic factors: A retrospective cohort study. Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA). 2025;13(02). doi:10.64666/joecsa.2024.66

BibTeX
@article{Masuki2025,
  author = {Masuki, Heavenlight and Mhina, Celina and Sanyiwa, A},
  title = {Retinoblastoma in Tanzania; Survival and prognostic factors: A retrospective cohort study},
  journal = {Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA)},
  year = {2025},
  volume = {13},
  number = {02},
  doi = {10.64666/joecsa.2024.66}
}
Kostenlos starten →